Clinical Trials
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
S9700
A Phase II Trial of Infusional 5-Fluorouracil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito-C), and Dipyridamole (D) in Patients with Locally Advanced Unresected Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
09-15-1997
Closed
06-19-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9704
A Randomized Phase III Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotherapy Plus Rituximab for CD20+ B Cell Lymphomas(with Possible Late Autologous Stem Cell Transplant) for Patients with Diffuse Aggressive Non-Hodgkin's Lymphoma in the High-Intermediate and High Risk International Classification Prognostic Groups (A BMT Study)
Research Committee(s)
Lymphoma
Activated
09-15-1997
Closed
12-15-2007
Closed
Phase
Accrual
65%
Published
SWOG Clinical Trial Number
S9709
A Phase II Study to Evaluate Transoral CO2 Laser Supraglottic Laryngectomy and Irradiation in Stage I, II and III Squamous Cell Carcinoma of the Supraglottic Larynx
Research Committee(s)
Head and Neck Cancer
Activated
09-15-1997
Closed
12-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9706
A Phase II Trial of High Dose Cyclophosphamide Followed by Fludarabine in Patients with Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Research Committee(s)
Leukemia
Activated
09-15-1997
Closed
03-01-1999
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S9703
Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Systemic Chemotherapy with CHOP and Local Therapy with Involved Field Radiation in Patients with Malt Lymphomas
Research Committee(s)
Lymphoma
Activated
09-15-1997
Closed
03-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9705
Phase II Trial of Cisplatin, Etoposide and Paclitaxel (Taxol®) With G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
08-15-1997
Closed
07-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9632
Enhancing Well-Being During Breast Cancer Recurrence
Activated
06-01-1997
Closed
08-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9629
A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer
Activated
05-15-1997
Closed
03-15-1999
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
S9711
A Phase II Study of IL-4 in Patients with Relapsed or Refractory B Lineage Acute Lymphoblastic Leukemia.
Research Committee(s)
Leukemia
Activated
05-15-1997
Closed
08-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9714
A Phase II Trial of Paclitaxel by 96-Hour Infusion in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)
Research Committee(s)
Lung Cancer
Activated
05-15-1997
Closed
03-15-2000
Closed
Phase
SWOG Clinical Trial Number
SWOG-9444
Gastrointestinal Tumor Repository Protocol, Ancillary
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1997
Closed
09-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9625
Weekly Dose-Intensive Doxorubicin with Daily Oral Cyclophosphamide and Continuous G-CSF as Neoadjuvant Therapy for Locally Advanced and Inflammatory Breast Cancer, Phase II
Research Committee(s)
Breast Cancer
Activated
04-15-1997
Closed
08-15-1998
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
S9630
A Randomized Comparison of Medroxyprogesterone Acetate (MPA) and Observation For Prevention of Endometrial Pathology in Postmenopausal Breast Cancer Patients Treated with Tamoxifen
Research Committee(s)
Breast Cancer
Activated
03-15-1997
Closed
12-15-2004
Closed
Phase
Accrual
32%
Published
SWOG Clinical Trial Number
SWOG-9427
Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
03-01-1997
Closed
06-01-2000
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
S9627
Hydroxyurea, Etoposide (VP-16) and Dacarbazine (DTIC) [HED] for Patients with Unresectable or Metastatic GI Stromal Tumors, Phase II
Research Committee(s)
Sarcoma
Activated
03-01-1997
Closed
03-01-1999
Closed
Phase
Accrual
43%
Published
SWOG Clinical Trial Number
SWOG-9342
A Study of the Late Cardiac Effects of Two Different Adjuvant Chemotherapy Regimens in Women With Node Negative Breast Cancer Treated on SWOG-8897
Research Committee(s)
Breast Cancer
Activated
02-15-1997
Closed
11-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9511
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach
Activated
01-15-1997
Closed
11-15-1998
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S9622
Evaluation of CI-980 in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II
Research Committee(s)
Melanoma
Activated
12-15-1996
Closed
08-01-1998
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
SWOG-9430
A Phase II Trial of Complete Surgical Resection for Stage IV Melanoma-Surgical Resection with Biological and Clinical Follow-Up
Research Committee(s)
Melanoma
Activated
11-15-1996
Closed
11-15-2005
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9431
Cytogenetic, Molecular and Cellular Biology Studies in Metastatic Melanoma Patients, Ancillary
Research Committee(s)
Melanoma
Activated
11-15-1996
Closed
12-15-2005